| Heading: |
Cancer: Clinical Trials |
| Question ID: |
1799097 |
| UIN: |
49619 |
| House: |
Commons |
| Date tabled: |
2025-04-30 |
| Asking Member ID: |
5207 |
| Asking Member display name: |
Clive Jones
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Clive Jones
|
| Member interest: |
true |
| Question text: |
To ask the Secretary of State for Health and Social Care, for what reason age is used to determine eligibility for cancer clinical trials; and whether he is taking steps to ensure that people aged between 16 and 24 have equitable access to such trials. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-05-06 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department is committed to maximising the United Kingdom’s potential to lead the world in clinical research, with the aim of ensuring that all patients, including teenagers and young adults with cancer, have access to cutting-edge clinical trials and ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |